1. Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
- Author
-
Davar, Diwakar, Morrison, Robert M., Dzutsev, Amiran K., Karunamurthy, Arivarasan, Chauvin, Joe-Marc, Amatore, Florent, Deutsch, Julie S., Das Neves, Rodrigo X., Rodrigues, Richard R., McCulloch, John A., Wang, Hong, Hartman, Douglas J., Badger, Jonathan H., Fernandes, Miriam R., Bai, Yulong, Sun, Jie, Cole, Alicia M., Aggarwal, Poonam, Fang, Jennifer R., Deitrick, Christopher, Bao, Riyue, Duvvuri, Umamaheswar, Sridharan, Shaum S., Kim, Seungwon W., A. Choudry, Haroon, Holtzman, Matthew P., Pingpank, James F., O'Toole, James Patrick, DeBlasio, Richelle, Jin, Yang, Ding, Quanquan, Gao, Wentao, Groetsch, Christopher, Pagliano, Ornella, Rose, Amy, Urban, Corey, Singh, Jagjit, Divarkar, Prajan, Mauro, David, Bobilev, Dmitri, Wooldridge, James, Krieg, Arthur M., Fury, Matthew G., Whiteaker, Jeffrey R., Zhao, Lei, Paulovich, Amanda G., Najjar, Yana G., Luke, Jason J., Kirkwood, John M., Taube, Janis M., Park, Hyun Jung, Trinchieri, Giorgio, and Zarour, Hassane M.
- Published
- 2024
- Full Text
- View/download PDF